Some important considerations on the evaluation of male reproductive toxicity for pharmaceuticals and introduction of FDA's related guidances
ZHANG Li-jiang
HUANG Fang-hua
WANG Qing-li
ZHENG Gao-li
Keywords:male reproductive toxicitypharmaceuticalsguidancesimportant considerations
Publication Date:2016-01-01
Online Publishing Date:2026-08-14(First online date of this platform, not the publication date of the document)
